Načítá se...
Development of sequence-specific antimicrobials based on programmable CRISPR-Cas nucleases
Antibiotics target conserved bacterial cellular pathways or growth functions and therefore cannot selectively kill specific members of a complex microbial population. Here, we develop programmable, sequence-specific antimicrobials using the RNA-guided nuclease Cas9(1, 2) delivered by a bacteriophage...
Uloženo v:
| Vydáno v: | Nat Biotechnol |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4317352/ https://ncbi.nlm.nih.gov/pubmed/25282355 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nbt.3043 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|